Wynand P Roos

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Molecules (Basel, Switzerland)

Molecular cancer research : MCR

Cancer research

Chemistry (Weinheim an der Bergstrasse, Germany)

Johannes Gutenberg Universitat Universitatsmedizin

University of Stellenbosch Department of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johannes Gutenberg Universitat Universitatsmedizin

Germany

Primary Investigator :: Toxicology

Education History

University of Stellenbosch Department of Medicine

South Africa

PHD :: Medical Biochemistry

University of Stellenbosch Faculty of Science

South Africa

BSC :: Biochemistry

University of Stellenbosch Faculty of Science

South Africa

BSC

Publications

Luay J Rashan, Nadire Özenver, Joelle C Boulos, Mona Dawood, Wynand P Roos, Katrin Franke, Ioannis Papasotiriou, Ludger A A Wessjohann, Heinz-Herbert Fiebig, Thomas Efferth
Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules (Basel, Switzerland) 28 (4) (2023)
Luay J Rashan, Nadire Özenver, Joelle C Boulos, Mona Dawood, Wynand P Roos, Katrin Franke, Ioannis Papasotiriou, Ludger A A Wessjohann, Heinz-Herbert Fiebig, Thomas Efferth
Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules (Basel, Switzerland) 28 (4) (2023)
Luay J Rashan, Nadire Özenver, Joelle C Boulos, Mona Dawood, Wynand P Roos, Katrin Franke, Ioannis Papasotiriou, Ludger A A Wessjohann, Heinz-Herbert Fiebig, Thomas Efferth
Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules (Basel, Switzerland) 28 (4) (2023)
Luay J Rashan, Nadire Özenver, Joelle C Boulos, Mona Dawood, Wynand P Roos, Katrin Franke, Ioannis Papasotiriou, Ludger A A Wessjohann, Heinz-Herbert Fiebig, Thomas Efferth
Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules (Basel, Switzerland) 28 (4) (2023)
Franziska R Traube, Natércia F Brás, Wynand P Roos, Corinna C Sommermann, Tamara Diehl, Robert J Mayer, Armin R Ofial, Markus Müller, Hendrik Zipse, Thomas Carell
Epigenetic Anti-Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (26) (2022)
Daniela Hanisch, Andrea Krumm, Tamara Diehl, Carla M Stork, Mario Dejung, Falk Butter, Ella Kim, Walburgis Brenner, Gerhard Fritz, Thomas G Hofmann, Wynand P Roos
Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression. Cell death & disease 13 (4) (2022)
Nicole Kiweler, Helena Schwarz, Alexandra Nguyen, Stephanie Matschos, Christina Mullins, Andrea Piée-Staffa, Christina Brachetti, Wynand P Roos, Günter Schneider, Michael Linnebacher, Walburgis Brenner, Oliver Holger Krämer
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil. Cell biology and toxicology (2022)
Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher, Jana V Stuijvenberg, Matthias Ulrich Kassack, Wolfgang A Schulz, Wynand P Roos, Finn K Hansen, Marc Pflieger, Thomas Kurz, Gerhard Fritz
In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi). International journal of molecular sciences 21 (13) (2020)
Yang He, Wynand P Roos, Qianchao Wu, Thomas G Hofmann, Bernd Kaina
The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death. Molecular cancer research : MCR 17 (5) (2019)
Dorthe Aasland, Laura Götzinger, Laura Hauck, Nancy Berte, Jessica Meyer, Melanie Effenberger, Simon Schneider, Emelie E Reuber, Wynand P Roos, Maja T Tomicic, Bernd Kaina, Markus Christmann
Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB. Cancer research 79 (1) (2018)

Wynand P Roos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wynand P Roos